OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Urology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	222
Texture analysis for patient selection	210
Single-cell and spatial sequencing of kidney cancer	158
Human-relevant urothelial model provides insight into infection strategies and host response	143
Krause corpuscles act as genital vibration detectors	129
Semen quality recovery following COVID-19	102
PARP inhibitors plus enzalutamide to treat mCRPC	86
Urine microbiota differ in bladder cancer	81
Considering urology in a planetary context	80
Time for women-centred gynaecology	76
Advancing the state of the art in congenital obstructive uropathy	75
The clinical utility of prostate MRI before biopsy	75
Symptoms and subtypes of patients with lower urinary tract dysfunction — insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network	73
Preclinical models of bladder cancer: BBN and beyond	72
High-dose chemotherapy for relapsed testicular germ cell tumours	66
A clinical guide to rare male sexual disorders	62
Micro-ultrasound for prostate cancer	60
FOXA2–KIT-driven lineage plasticity in NEPC	58
Proteomic-based analysis of testicular interstitial fluid	58
Overcoming antibiotic resistance in complicated UTI	57
A new text message-based platform for self-management of patients with IC/BPS	57
Madrid plays host to a celebration of urology	55
What happens in Vegas … shapes the future of urology	53
Microfluidic sperm selection	51
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	50

Leveraging generative AI to enhance doctor–patient communication	50
Promise without practice — charting the path forward for bladder cancer biomarkers	50
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	48
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	48
Metaverse in surgery — origins and future potential	47
Pembrolizumab + axitinib beyond first-line therapy for mRCC	46
A non-invasive assay for UTUC diagnosis	46
COVID can’t kill CopMich collaboration	43
Vaccination to prevent untreatable gonorrhoea	42
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility	41
Measuring and improving the cradle-to-grave environmental performance of urological procedures	41
The mechanism of action of neuromodulation in the treatment of overactive bladder	41
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	37
Personalized 3D models for prostate cancer surgery	37
PEACEing together prostate cancer therapy	36
Efficacy of the Revi system in treating urgency urinary incontinence	36
Resolving the puzzle of same-sex sexual interactions	36
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	36
EMUC25: shaping tomorrow’s uro-oncology care	35
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	34
Mohs micrographic surgery and reconstruction for glans and urethral squamous cell carcinoma	33
Transitional urology: a comprehensive review of the transitional care process	33
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	32
Effect of high glucose on E. coli	32
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	32
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	31
Women in urology: the past	29
Cribriform morphology affects mpMRI imaging	29
The magic of MagSToNE	29
Promising efficacy of UTI vaccines as an alternative to antibiotics	28
AUA returns to its former glory in Chicago	28
Robots learning to imitate surgeons — challenges and possibilities	28
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	28
Videourodynamics — role, benefits and optimal practice	27
Technical modifications to improve erectile function recovery after radical prostatectomy	27
A clinical overview of people living with HIV and genitourinary cancer care	26
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	26
Successful mentorship for women in urology — a new era	26
Microultrasonography-guided prostate cancer biopsy	26
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective	25
Secondary kidney stones — remove or leave?	24
Prostate cancer in transgender women — challenges in research and clinical care	24
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	23
Is it time to rethink the current patient-reported outcome measures?	23
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	22
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	21
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	20
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	20
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	20
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	20

De-clear cell differentiated renal cell carcinoma — a new therapeutic target	19
Pride, not prejudice	19
Management and cost of stent encrustation in pregnancy	19
Turning up the heat: CTLA4 blockade in urothelial cancer	18
AI for antibiotic design	18
Epigenetic modulation of prostate cancer disparities in men with African ancestry	17
Beyond maternal exercise: paternal exercise adaptations mediated by sperm microRNA signatures	17
The evolving treatment landscape of metastatic urothelial cancer	16
The future of patient-derived xenografts in prostate cancer research	16
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	16
The prognostic role of stroma in UTUC	16
Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health	16
What is new in the updated National Institute for Health and Care Excellence (NICE) fertility problems guideline 2026?	16
The value of women urologists — individual and institutional imperatives to address salary equity	16
Uncovering a link between COVID-19 and renal cell carcinoma	15
Pelvic-fascia-sparing techniques and outcomes with RARP	15
Turning back time in the testes	15
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy	14
Och AI the noo from SIU	14
We all get erections — de-gendering sexual arousal dysfunction in the ICD	14
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	14
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	14
Urinary tract infections in children	13
Hallmark discoveries in the biology of Wilms tumour	13
Current and future pharmacotherapy for female sexual dysfunction	13
Improved phenotypic classification of male infertility to promote discovery of genetic causes	13
Men hold the balance of power	12
Power up to investigate PrEP	12
The shifting treatment paradigm of metastatic renal cell carcinoma	12
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	12
CMA mediates resistance to androgen inhibitors in prostate cancer	12
Mellow yellow: BilR reduces bilirubin to urobilinogen	11
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	11
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications	11
Metabolism, mitochondria and metastasis in kidney cancer	11
Tuft cells in prostate cancer	11
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	11
Male infertility and somatic health — insights into lipid damage as a mechanistic link	11
Diagnosis of ccRCC	11
Spatiotemporal trends in human semen quality	11
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	10
Pronouns in English: a user’s guide	10
Sperm activity affected by endometriosis	10
Advances in sliding clip renorrhaphy for partial nephrectomy	10
Semen parameters across testicular cancer stages	10
Stepping up to prevent bacterial vaginosis recurrence	10
Syphilis on the rise — a need for alternative therapies and vaccines	10
MRI diagnosis and radical prostatectomy outcomes	10
Chlorination by-products in drinking water — association with bladder cancer risk	10
The ins and outs of penile erection	10
Urology on a changing planet: links between climate change and urological disease	9
Particulate matter leaves a bitter taste in testes	9
Visual clues — dermatological manifestations of sexually transmitted infections in men	9
Testosterone replacement therapy and spermatogenesis in reproductive age men	9
Artificial intelligence in the management of prostate cancer	9
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	9
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	9
EAU26: innovation, patient care and a touch of mythology	8
Feasibility and potential of an MRI-based prostate cancer screening	8
Influence of substance use on male reproductive health and offspring outcomes	8
Smooth muscle cell plasticity in pelvic organ prolapse	8
Genetic and biological drivers of prostate cancer disparities in Black men	8
Clinical trial design for non-muscle-invasive bladder cancer	8
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	8